Exagen (XGN) Income from Continuing Operations (2018 - 2026)
Exagen (XGN) reported Income from Continuing Operations of 3967000.0 for Q1 2026, down 5.73% on a YoY basis from 4208137.97 in Q1 2025, and up 15.11% quarter-over-quarter from 4673000.0 in Q4 2025.
Exagen (XGN) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Exagen has reported Income from Continuing Operations for 9 years, with the latest figure at 3967000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 5.73% year-over-year to 3967000.0; the trailing twelve-month figure through Mar 2026 stood at 20166000.0 (down 30.04% YoY), and the FY2025 full-year result was 19951000.0, down 31.99% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3967000.0, up from 4673000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2966000.0 in Q2 2024, with the low at 15117000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 6540176.47 across 5 years, with a median of 5028000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 128.86% — and 2023, when it surged 65.83%.
- Exagen's Income from Continuing Operations stood at 15117000.0 in 2022, then surged by 63.35% to 5540000.0 in 2023, then jumped by 32.11% to 3761000.0 in 2024, then retreated by 24.25% to 4673000.0 in 2025, then climbed by 15.11% to 3967000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3967000.0 (Q1 2026), 4673000.0 (Q4 2025), and 7087000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | -3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -4.67 Mn |
| Sep 30, 2025 | -7.09 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | -3.76 Mn |
| Sep 30, 2024 | -5.03 Mn |
| Jun 30, 2024 | -2.97 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | -5.54 Mn |
| Sep 30, 2023 | -5.42 Mn |
| Jun 30, 2023 | -5.01 Mn |
| Mar 31, 2023 | -7.69 Mn |
| Dec 31, 2022 | -15.12 Mn |
| Sep 30, 2022 | -8.44 Mn |
| Jun 30, 2022 | -14.67 Mn |
| Mar 31, 2022 | -10.27 Mn |
| Dec 31, 2021 | -7.05 Mn |
| Sep 30, 2021 | -7.18 Mn |
| Jun 30, 2021 | -6.41 Mn |